Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Fitoterapia ; 168: 105546, 2023 Jul.
Article de Anglais | MEDLINE | ID: mdl-37217021

RÉSUMÉ

Phoma fungi are known to produce a diverse range of natural products which possess various biological activities such as antifungal, antimicrobial, insecticidal, cytotoxic, and immunomodulatory effects. In our present study, we have isolated two novel polyketides (1 and 3), one new sesquiterpenoid (2), and eight known compounds (4-11) from the culture of Phoma sp. 3A00413, a deep-sea sulphide-derived fungus. The structures of compounds 1-3 were elucidated using NMR, MS, NMR calculation, and ECD calculation. In vitro antibacterial activities of all the isolated compounds were evaluated against Escherichia coli, Vibrio parahaemolyticus vp-HL, Vibrio parahaemolyticus, Staphylococcus aureus, Vibrio vulnificus, and Salmonella enteritidis. Compounds 1, 7, and 8 exhibited weak inhibition against Staphylococcus aureus growth, while compounds 3 and 7 showed weak inhibition against Vibrio vulnificus growth. Importantly, compound 3 demonstrated exceptional potency against Vibrio parahaemolyticus, with a minimum inhibitory concentration (MIC) of 3.1 µM.


Sujet(s)
Phoma (genre) , Polycétides , Sesquiterpènes , Antibactériens/composition chimique , Antibactériens/isolement et purification , Antibactériens/pharmacologie , Tests de sensibilité microbienne , Structure moléculaire , Phoma (genre)/composition chimique , Polycétides/composition chimique , Polycétides/isolement et purification , Polycétides/pharmacologie , Sesquiterpènes/composition chimique , Sesquiterpènes/isolement et purification , Sesquiterpènes/pharmacologie , Spectroscopie par résonance magnétique , Bactéries/effets des médicaments et des substances chimiques
2.
Molecules ; 27(4)2022 Feb 10.
Article de Anglais | MEDLINE | ID: mdl-35208971

RÉSUMÉ

The aim of our study was to examine the different concentrations of AuNPs as a new antimicrobial substance to control the pathogenic activity. The extracellular synthesis of AuNPs performed by using Phoma sp. as an endophytic fungus. Endophytic fungus was isolated from vascular tissue of peach trees (Prunus persica) from Baft, located in Kerman province, Iran. The UltraViolet-Visible Spectroscopy (UV-Vis spectroscopy) and Fourier transform infrared spectroscopy provided the absorbance peak at 526 nm, while the X-ray diffraction and transmission electron microscopy images released the formation of spherical AuNPs with sizes in the range of 10-100 nm. The findings of inhibition zone test of Au nanoparticles (AuNPs) showed a desirable antifungal and antibacterial activity against phytopathogens including Rhizoctonia solani AG1-IA (AG1-IA has been identified as the dominant anastomosis group) and Xanthomonas oryzae pv. oryzae. The highest inhibition level against sclerotia formation was 93% for AuNPs at a concentration of 80 µg/mL. Application of endophytic fungus biomass for synthesis of AuNPs is relatively inexpensive, single step and environmentally friendly. In vitro study of the antifungal activity of AuNPs at concentrations of 10, 20, 40 and 80 µg/mL was conducted against rice fungal pathogen R. solani to reduce sclerotia formation. The experimental data revealed that the Inhibition rate (RH) for sclerotia formation was (15, 33, 74 and 93%), respectively, for their corresponding AuNPs concentrations (10, 20, 40 and 80 µg/mL). Our findings obviously indicated that the RH strongly depend on AuNPs rates, and enhance upon an increase in AuNPs rates. The application of endophytic fungi biomass for green synthesis is our future goal.


Sujet(s)
Antibactériens , Antifongiques , Biomasse , Endophytes/composition chimique , Or , Nanoparticules métalliques/composition chimique , Phoma (genre)/composition chimique , Rhizoctonia/croissance et développement , Xanthomonas/croissance et développement , Antibactériens/composition chimique , Antibactériens/pharmacologie , Antifongiques/composition chimique , Antifongiques/pharmacologie , Évaluation préclinique de médicament , Or/composition chimique , Or/pharmacologie
3.
Molecules ; 25(23)2020 Nov 24.
Article de Anglais | MEDLINE | ID: mdl-33255301

RÉSUMÉ

In our ongoing search for new bioactive fungal metabolites, four previously undescribed oxazole carboxylic acid derivatives (1-4) for which we proposed the trivial names macrooxazoles A-D together with two known tetramic acids (5-6) were isolated from the plant pathogenic fungus Phoma macrostoma. Their structures were elucidated based on high-resolution mass spectrometry (HR-MS) and nuclear magnetic resonance (NMR) spectroscopy. The hitherto unclear structure of macrocidin Z (6) was also confirmed by its first total synthesis. The isolated compounds were evaluated for their antimicrobial activities against a panel of bacteria and fungi. Cytotoxic and anti-biofilm activities of the isolates are also reported herein. The new compound 3 exhibited weak-to-moderate antimicrobial activity as well as the known macrocidins 5 and 6. Only the mixture of compounds 2 and 4 (ratio 1:2) showed weak cytotoxic activity against the tested cancer cell lines with an IC50 of 23 µg/mL. Moreover, the new compounds 2 and 3, as well as the known compounds 5 and 6, interfered with the biofilm formation of Staphylococcus aureus, inhibiting 65%, 75%, 79%, and 76% of biofilm at 250 µg/mL, respectively. Compounds 5 and 6 also exhibited moderate activity against S. aureus preformed biofilm with the highest inhibition percentage of 75% and 73% at 250 µg/mL, respectively.


Sujet(s)
Acides carboxyliques/composition chimique , Oxazoles/composition chimique , Phoma (genre)/composition chimique , Anti-infectieux/composition chimique , Anti-infectieux/isolement et purification , Anti-infectieux/pharmacologie , Biofilms/effets des médicaments et des substances chimiques , Acides carboxyliques/isolement et purification , Acides carboxyliques/pharmacologie , Humains , Spectroscopie par résonance magnétique , Tests de sensibilité microbienne , Conformation moléculaire , Structure moléculaire , Phoma (genre)/métabolisme , Maladies des plantes/microbiologie , Métabolisme secondaire , Staphylococcus aureus/effets des médicaments et des substances chimiques , Relation structure-activité
4.
Bioorg Chem ; 104: 104317, 2020 11.
Article de Anglais | MEDLINE | ID: mdl-33142426

RÉSUMÉ

Nine new (1-9) and four known (10-13) [13]cytochalasins, along with three known 24-oxa[14]cytochalasins (14-16), were isolated from the culture of Phoma multirostrata XJ-2-1, an endophytic fungus obtained from the fibrous root of Parasenecio albus. Their structures were elucidated by interpretation of the nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectroscopy (HRESIMS). The absolute configurations were assigned by single-crystal X-ray crystallography, modified Mosher's method, and by analysis of their experimental electronic circular dichroism (ECD) spectra. Compound 6 could induce cell cycle arrest at G2-phase in CT26 and A549 cells, and displayed moderate cytotoxicity against CT26 and A549 cell lines with IC50 values of 6.03 and 5.04 µM, respectively. Co-treatment of 7-9, 13 and 16 with tumor necrosis factor related apoptosis inducing ligand (TRAIL) could significantly decrease the cell viability of A549, which revealed that cytochalasins could possibly be a new group of TRAIL sensitizers in lung cancer therapy.


Sujet(s)
Antinéoplasiques/pharmacologie , Cytochalasines/pharmacologie , Phoma (genre)/composition chimique , Ligand TRAIL/antagonistes et inhibiteurs , Antinéoplasiques/composition chimique , Antinéoplasiques/isolement et purification , Apoptose/effets des médicaments et des substances chimiques , Points de contrôle du cycle cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Cytochalasines/composition chimique , Cytochalasines/isolement et purification , Relation dose-effet des médicaments , Tests de criblage d'agents antitumoraux , Humains , Structure moléculaire , Phoma (genre)/métabolisme , Relation structure-activité , Ligand TRAIL/métabolisme , Cellules cancéreuses en culture
5.
Org Biomol Chem ; 18(21): 4056-4062, 2020 06 07.
Article de Anglais | MEDLINE | ID: mdl-32412573

RÉSUMÉ

Ergocytochalasin A (1), an unprecedented merocytochalasan formed via Diels-Alder cycloaddition of a cytochalasin with an ergosterol, was isolated from an endophytic fungus Phoma multirostrata XJ-2-1. Compound 1 possessed a unique 5/6/14/6/5/6/6/6 fused octacyclic ring system and its structure was established by detailed NMR and HRESIMS spectroscopic analyses. The absolute configuration of 1 was determined by single-crystal X-ray diffraction. A plausible biogenetic pathway of 1 was postulated. Compound 1 was evaluated for its cytotoxicity against six cancer cell lines and showed inhibitory effects with IC50 values ranging from 6.92 to 26.63 µM. The in vitro immunosuppressive activity of 1 against ConA-induced T cell and LPS-induced B cell proliferation, as well as its antiviral activity against Human dengue virus type 3 (DV3), influenza A virus (H1N1) and respiratory syncytial virus (RSV), was also evaluated. Ergocytochalasin A is the first example of a merocytochalasan which consists of one cytochalasin moiety and one ergosterol moiety. Containing eighteen chiral centers, ergocytochalasin A owns a folded framework, which makes it extremely compact in space.


Sujet(s)
Antiviraux/pharmacologie , Virus de la dengue/effets des médicaments et des substances chimiques , Sous-type H1N1 du virus de la grippe A/effets des médicaments et des substances chimiques , Phoma (genre)/composition chimique , Virus respiratoire syncytial humain/effets des médicaments et des substances chimiques , Antiviraux/composition chimique , Antiviraux/isolement et purification , Lymphocytes B/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Concanavaline A/antagonistes et inhibiteurs , Concanavaline A/pharmacologie , Virus de la dengue/classification , Humains , Lipopolysaccharides/antagonistes et inhibiteurs , Lipopolysaccharides/pharmacologie , Lymphocytes T/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE